The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma

Journal of Hepatology

Volumn 55, Issue 4, 2011, Pages 814-819

  Merani, Shaheed ^a   Majno, Pietro ^b   Kneteman, Norman M ^a   Berney, Thierry ^b   Morel, Philippe ^b   Mentha, Gilles ^b   Toso, Christian ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alpha fetoprotein; Hepatocellular cancer; Liver transplantation; Registry; Tumor volume

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER PATIENT; CHEMOEMBOLIZATION; FEMALE; GRAFT SURVIVAL; HEMOCHROMATOSIS; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SURVIVAL RATE; TRANSARTERIAL CHEMOEMBOLISATION; TREATMENT OUTCOME; TUMOR VOLUME;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 80051910504     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.12.040     Document Type: Article

References (24)

1. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699 (Pubitemid 26079803)
2. F.Y. Yao, R.K. Kerlan Jr., R. Hirose, T.J. Davern III, N.M. Bass, and S. Feng Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
3. M. Ravaioli, G.L. Grazi, F. Piscaglia, F. Trevisani, M. Cescon, and G. Ercolani Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the milan selection criteria Am J Transplant 8 2008 2547 2557
4. C. Toso, S. Asthana, D.L. Bigam, A.M. Shapiro, and N.M. Kneteman Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database Hepatology 49 2009 832 838
5. V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
6. E.A. Pomfret, K. Washburn, C. Wald, M.A. Nalesnik, D. Douglas, and M. Russo Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States Liver Transpl 16 2010 262 278
7. P.E. Majno, R. Adam, H. Bismuth, D. Castaing, A. Ariche, and J. Krissat Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
8. S. Roayaie, J.S. Frischer, S.H. Emre, T.M. Fishbein, P.A. Sheiner, and M. Sung Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539 (Pubitemid 34258353)
9. G. Otto, S. Herber, M. Heise, A.W. Lohse, C. Monch, and F. Bittinger Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver transpl 12 2006 1260 1267 (Pubitemid 44194595)
10. G. Millonig, I.W. Graziadei, M.C. Freund, W. Jaschke, S. Stadlmann, and R. Ladurner Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver transpl 13 2007 272 279 (Pubitemid 46351654)
11. W.C. Chapman, M.B. Majella Doyle, J.E. Stuart, N. Vachharajani, J.S. Crippin, and C.D. Anderson Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617 625
12. J.Y. Leung, A.X. Zhu, F.D. Gordon, D.S. Pratt, A. Mithoefer, and K. Garrigan Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study Liver transpl 10 2004 1343 1354 (Pubitemid 39530049)
13. K. Han, G.N. Tzimas, J.S. Barkun, P. Metrakos, J.L. Tchervenkov, and N. Hilzenrat Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation Can J Gastroenterol 21 2007 39 45 (Pubitemid 46277174)
14. E. Vibert, D. Azoulay, E. Hoti, S. Iacopinelli, D. Samuel, and C. Salloum Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor Am J Transplant 10 2010 129 137
15. C. Toso, G. Mentha, N. Kneteman, and P. Majno The place of downstaging for hepatocellular carcinoma J Hepatol 52 2010 930 936
16. Scientific Registry of Transplant Recipients. The 2006 SRTR report on the state of transplantation. 5th ed.; 2007. p. 1317-1433.
17. C. Toso, J. Trotter, A. Wei, D.L. Bigam, S. Shah, and J. Lancaster Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma Liver transpl 14 2008 1107 1115
18. C.H. Kwon, D.J. Kim, Y.S. Han, J.B. Park, G.S. Choi, and S.J. Kim HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 25 2007 313 319 (Pubitemid 350014959)
19. X. Xu, Q.H. Ke, Z.X. Shao, J. Wu, J. Chen, and L. Zhou The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma Dig Dis Sci 54 2009 385 388
20. S.S. Zheng, X. Xu, J. Wu, J. Chen, W.L. Wang, and M. Zhang Liver transplantation for hepatocellular carcinoma: hangzhou experiences Transplantation 85 2008 1726 1732
21. C. Toso, N.M. Kneteman, A.M. James Shapiro, and D.L. Bigam The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria Transpl Int 22 2009 869 875
22. S. Feng, N.P. Goodrich, J.L. Bragg-Gresham, D.M. Dykstra, J.D. Punch, and M.A. Debroy Characteristics associated with liver graft failure: the concept of a donor risk index Am J Transplant 6 2006 783 790 (Pubitemid 43345017)
23. C. Toso, S. Merani, D.L. Bigam, A.M. Shapiro, and N.M. Kneteman Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma Hepatology 51 2010 1237 1243
24. X. Xu, Q.H. Ke, Z.X. Shao, J. Wu, J. Chen, and L. Zhou The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma Dig Dis Sci 54 2009 385 388